Every material event, decoded in plain English — what each one means for the stock.
AllSight quality score: 57/100 — a percentile rank of BOSTON SCIENTIFIC CORP’s fundamentals against Manufacturing peers, weakest on financial health. A quality ranking, not a price prediction.
| P / E | 19.7× |
| P / S | 3.4× |
| EV / EBITDA | 14.2× |
| Gross margin | 69.9% |
| Operating margin | 19.8% |
| Net margin | 17.5% |
| Return on equity | 14.7% |
| ROIC | 10.6% |
| Revenue growth | 13.5% |
| Debt / equity | 0.5× |
Valuation today: P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from BOSTON SCIENTIFIC CORP’s own financial statements and shown as context, never as advice.